Miraculins Files with Health Canada for PreVu Medical Device License
A class II medical device license application was filed for the Non-Invasive Skin Cholesterol Point of Care test
News & Media
PROVINCE LAUNCHES NEW BIOMASS ENERGY SUPPORT PROGRAM
$400,000 in grants provide financial incentive to use biomass.
ANIM, Manitoba's Bilingual Trade Agency, Receives Government Funding in Support of Centrallia 2012
Thanks to combined investments of $1.2 million from the Governments of Canada and of Manitoba business leaders from around the world will have an opportunity to participate in Centralia 2012.
The Manitoba division of the Canadian Manufacturers and Exporters announces 2012 award winners
Congratulations to Conviron for winning Manitoba's Exporter of the Year and Intelligent Hospital Systems for winning the CME's Emerging award.
Invitation to Centrallia Information Sessions
Centrallia 2012 is what we're calling speed-dating for business. We want to hook you up and help you build new relationships, so your business prospers.
DiaMedica’s DM-204 for Type 2 Diabetes Successfully Humanized
DiaMedica announced the successful humanization of its monoclonal antibody DM-204 for Type 2 diabetes and diabetic related complications of hypertension and cholesterol.
New ventures on the horizon
Intelligent Hospital Systems is building its order book for its million-dollar robotic pharmaceutical dispensers
Intelligent Hospital Systems announces enhanced RIVA
Intelligent Hospital Systems has announced the release of a new enhanced version of Robotic Intravenous Automation.
DiaMedica's DM-199 for Type 1 Diabetes significantly delays autoimmune attack and demonstrates a dramatic increase in C-Peptide levels
DiaMedica reported that chronic administration of DM-199 significantly delayed the autoimmune attack, preserved beta cell mass and demonstrated a 12-fold increase in circulating C-peptide levels in an in vivo study.
Medicure Reports First Quarter 2012 Financial Results
Medicure reported a first-quarter profit of $23.5 million, reversing a year-ago net loss of $1.6 million as it booked a $23.9-million non-cash gain on a debt settlement.
DiaMedica’s DM-204 for Type 2 Diabetes Significantly Lowers Blood Glucose, Blood Pressure and Cholesterol Levels
DiaMedica presented new compelling Type 2 diabetes data from studies of DM-204 at the Windhover Therapeutic Area Partnership Conference in Boston, MA, USA.
Turning New Ideas into a Competitive Advantage for the Agriculture Sector
The $50 million Agricultural Innovation Program, which will boost the development and commercialization of innovative new products, technologies and processes in the agricultural sector was announced by Agriculture Minister Gerry Ritz.
GlaxoSmithKline Inc. Launches $50 Million Life Sciences Innovation Fund in Canada
GSK announced the launch of a new national fund that will significantly advance the commercialization of scientific innovation in Canada by investing in early stage breakthrough research.
Financial boost for custom prosthesis maker
Wendy Smith, a local prosthetist whose quest to build a better breast for women who have undergone a full or partial mastectomy just got a $97,000 financial boost from the federal government.
More 'incubators' growing tech firms
Business incubators are designed to help technology companies grow in all sorts of ways.
There must always be passion
Last week, Burt Rutan, named Entrepreneur of the Year by Inc. magazine and one of "the world's 100 most influential people" by Time magazine, imparted some innovation tips to a Winnipeg audience with a vested interest in triggering more innovation-based e
Medicure Announces Graduation to TSX Venture Exchange
Medicure Inc. is pleased to announce that the TSX Venture Exchange has granted approval for Medicure to graduate from the NEX, to the TSX Venture Exchange as a Tier 2 issuer.
BIOFIBE 2011 Conference brings together industry leaders
Serious players in the biomaterials and bioenergy fields from around the world have converged on Winnipeg for the three-day BIOFIBE2011 Conference.
R&D Tax Scheme Too Rich: Federal Panel
Ottawa needs to overhaul its flagship R & D program because it spends too much money and fails to show any increase in innovation among Canadian companies, says a federally appointed panel of experts.
Manitoba Announces New Supports for Small Businesses and Entrepreneurs
As part of Small Business Week, the province is unveiling two new programs, AccessManitoba and Business Programs and Services (BizPaS) to help support small businesses and entrepreneurs set up shop, access services and provide better customer service, Ent
DiaMedica Named 2011 Emerging Company of the Year by Life Science Association of Manitoba
The Emerging Life Science Company of the Year award celebrates a company based in Manitoba that is recognized for their growth potential.